Hesperidin
- hesperidin
- 520-26-3
- Cirantin
- Hesperidoside
- Hesper bitabs
- Create:2005-06-24
- Modify:2025-01-18
- 2S, Hesperidin
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-
- 7-Rhamnoglucoside, Hesperetin
- Hesperetin 7 Rhamnoglucoside
- Hesperetin 7 Rutinoside
- hesperetin 7-rhamnoglucoside
- Hesperetin-7-Rutinoside
- Hesperidin
- Hesperidin 2S
- hesperidin
- 520-26-3
- Cirantin
- Hesperidoside
- Hesper bitabs
- Hesperetin 7-rhamnoglucoside
- Hesperetin-rutinosid
- Hesperidine
- Hesperetin 7-rutinoside
- Ciratin
- (S)-(-)-Hesperidin
- CCRIS 3940
- EINECS 208-288-1
- (2S)-Hesperidin
- NSC 44184
- UNII-E750O06Y6O
- BRN 0075140
- DIOSVEIN
- Hesperetin-7-O-rhamnoglucoside
- Hesperidin, (2S)-
- DTXSID9044328
- Hesperetin-7-rutinoside
- CHEBI:28775
- E750O06Y6O
- Hesperetin 7-O-rutinoside
- USAF CF-3
- Hesperitin-7-rhamnoglucoside
- (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one
- Hesperidin, (S)-(-)-
- 3',5'-Dihydroxy-4'-methoxy-7-rutinosyloxyflavan-4-on
- MLS001304066
- (s)-7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one
- DTXCID7024328
- EC 208-288-1
- MFCD00075663
- 5-18-05-00218 (Beilstein Handbook Reference)
- Hesperidin (JAN)
- Hesperetin, 7-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside)
- NSC-44184
- (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one
- (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-
- 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyl)oxy)-4-chromanon
- 7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, (S)-
- 7-(6-O-Desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanon
- SMR000718775
- HESPERIDIN [JAN]
- HESPERIDIN (MART.)
- HESPERIDIN [MART.]
- HESPERIDIN (USP-RS)
- HESPERIDIN [USP-RS]
- Aurantiamarin (Methyl Hesperidin)
- 3',5'-DIHYDROXY-4'-METHOXY-7-RUTINOSYLOXYFLAVAN-4-ONE
- hesperetin 7-(6-O-alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside
- NSC44184
- Hesperidin 2S
- 2S, Hesperidin
- (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one
- Hesperetin 7 Rutinoside
- SR-01000799145
- Hesperetin 7 Rhamnoglucoside
- Hesperidina
- Cirmtin
- 7-Rhamnoglucoside, Hesperetin
- Hesperidin,(S)
- NCGC00016481-01
- (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one (Hesperidin)
- (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-2H-pyran-2-yloxy)chroman-4-one
- CAS-520-26-3
- Hesperetin Glycoside
- Hesperidin (Standard)
- Hesperitin-7-rutinoside
- Hesperidin, >=80%
- HESPERIDIN [MI]
- DIOSMIN [NDI]
- Prestwick3_000400
- HESPERIDIN [VANDF]
- Glucopyranoside, hesperetin-7 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-
- HESPERIDIN [WHO-DD]
- SCHEMBL94586
- BSPBio_000619
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-
- cid_10621
- Hesperidin, analytical standard
- BPBio1_000681
- CHEMBL449317
- NDI 590 [FDMS]
- BCBcMAP01_000136
- BDBM61776
- NDI 590
- 2H-pyran-2-yloxy)chroman-4-one
- HMS2096O21
- HMS2233I03
- HMS3713O21
- Tox21_110448
- HY-15337R
- s2309
- AKOS015895450
- CCG-208580
- CS-5631
- DB04703
- KS-5308
- SMP1_000149
- NCGC00179501-01
- 1ST40133
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-
- HY-15337
- AB00513829
- H0049
- Hesperidin, mixture with analogeous compounds
- NS00008545
- C09755
- D01038
- (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- EN300-7419024
- Q385937
- Hesperidin, primary pharmaceutical reference standard
- methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-
- SR-01000799145-4
- SR-01000799145-5
- SR-01000799145-7
- 7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-
- BRD-K38903228-001-02-8
- BRD-K38903228-001-13-5
- Hesperidin, European Pharmacopoeia (EP) Reference Standard
- Hesperidin, Pharmaceutical Secondary Standard; Certified Reference Material
- Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-alpha-L-rhamnosyl-D-glucoside)
- (2S)-2-(4-methoxy-3-oxidanyl-phenyl)-7-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-oxidanyl-2,3-dihydrochromen-4-one
- (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxymethyl]-2-oxanyl]oxy]-3,4-dihydro-2H-1-benzopyran-4-one
- (2S)-7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE
- (2S)-7-((6-O-(6-DEOXY-alpha-L-MANNOPYRANOSYL)-beta-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE
- (S)-7-[[6-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
- 4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)-
- 5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-7-((6-O-.ALPHA.-L-RHAMNOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-4-CHROMANON
240.84 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
226.9 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
228.34 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
301.0728 999
302.076 131
286.0481 49
257.0802 34
325.0717 32
609.1866 999
610.189 388
301.072 286
611.183 64
302.0705 46
- Hesperetin (subclass of)
- Tangerine peel (part of)
Use (kg; approx.) in Germany (2009): >100
Consumption (g per capita; approx.) in Germany (2009): 0.00122
Calculated removal (%): 45.4
Not Classified
Reported as not meeting GHS hazard criteria by 42 of 42 companies. For more detailed information, please visit ECHA C&L website.
Aggregated GHS information provided per 42 reports by companies from 1 notifications to the ECHA C&L Inventory.
Reported as not meeting GHS hazard criteria per 42 of 42 reports by companies. For more detailed information, please visit ECHA C&L website.
There are 0 notifications provided by 0 of 42 reports by companies with hazard statement code(s).
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Status: Active Update: 28-05-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/14278
Status: Active Update: 04-03-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/25219
IMAP assessments - 4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-: Environment tier I assessment
IMAP assessments - 4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-: Human health tier I assessment
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=QUQPHWDTPGMPEX-QJBIFVCTSA-N
- Australian Industrial Chemicals Introduction Scheme (AICIS)4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-https://services.industrialchemicals.gov.au/search-assessments/4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-https://services.industrialchemicals.gov.au/search-inventory/
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/
- ChemIDplusChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_useHesperidinhttps://www.drugbank.ca/drugs/DB04703
- EPA Chemicals under the TSCA4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-https://www.epa.gov/chemicals-under-tscaEPA TSCA Classificationhttps://www.epa.gov/tsca-inventory
- EPA DSSToxCompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticeHesperidinhttps://chem.echa.europa.eu/100.007.536Hesperidin (EC: 208-288-1)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/67731
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- New Zealand Environmental Protection Authority (EPA)LICENSEThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.https://www.epa.govt.nz/about-this-site/general-copyright-statement/4H-1-Benzopyran-4-one, 7-6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyloxy-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-https://www.epa.govt.nz/industry-areas/hazardous-substances/guidance-for-importers-and-manufacturers/hazardous-substances-databases/
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ChEBI
- LOTUS - the natural products occurrence databaseLICENSEThe code for LOTUS is released under the GNU General Public License v3.0.https://lotus.nprod.net/Hesperidinhttps://www.wikidata.org/wiki/Q385937LOTUS Treehttps://lotus.naturalproducts.net/
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licence
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jsp
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloadsHESPERIDINhttps://www.dgidb.org/drugs/rxcui:5281
- Therapeutic Target Database (TTD)
- DailyMed
- EPA Chemical and Products Database (CPDat)EPA CPDat Classificationhttps://www.epa.gov/chemical-research/chemical-and-products-database-cpdat
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/HESPERIDINNORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- FDA Substances Added to FoodLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- FooDBLICENSEFooDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (FooDB) and the original publication.https://foodb.ca/aboutHesperidinhttps://foodb.ca/compounds/FDB002680
- Japan Chemical Substance Dictionary (Nikkaji)
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlPhytochemical compoundshttp://www.genome.jp/kegg-bin/get_htext?br08003.kegRisk category of Japanese OTC drugshttp://www.genome.jp/kegg-bin/get_htext?br08312.keg
- LIPID MAPSLipid Classificationhttps://www.lipidmaps.org/
- Natural Product Activity and Species Source (NPASS)
- MassBank Europe
- Metabolomics Workbench
- National Drug Code (NDC) DirectoryLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NIPH Clinical Trials Search of Japan
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmlhesperidinhttps://rxnav.nlm.nih.gov/id/rxnorm/5281
- Rhea - Annotated Reactions DatabaseLICENSERhea has chosen to apply the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). This means that you are free to copy, distribute, display and make commercial use of the database in all legislations, provided you credit (cite) Rhea.https://www.rhea-db.org/help/license-disclaimer
- SpectraBaseHesperidinehttps://spectrabase.com/spectrum/IA3FDpbBOj6#7;HESPERIDIN;3',5-DIHYDROXY-4'-METHOXY-FLAVANONE-7-O-BETA-[ALPHA-L-RHAMNOPYRANOSYL-(1->6)]-D-GLUCOPYRANOSIDE;HESPERETIN-7-O-BETA-[ALPHA-L-RHAMNOPYRANOSYL-(1->https://spectrabase.com/spectrum/DZFQj3zQ72w4'-METHOXY-3',5,7-TRIHYDROXYFLAVANONE, 7-[6-O-(6-DEOXY-alpha-L-MANNOPYRANOSYL)-beta-D-GLUCOPYRANOSIDE]https://spectrabase.com/spectrum/G4hUNpxayx8Hesperidinehttps://spectrabase.com/spectrum/G6j6EglEDCi
- Springer Nature
- Wikidatahesperidinhttps://www.wikidata.org/wiki/Q385937
- Wikipedia1,5-Cyclooctadienehttps://en.wikipedia.org/wiki/1,5-CyclooctadieneHesperidinhttps://en.wikipedia.org/wiki/Hesperidin
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.html
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 389599280https://pubchem.ncbi.nlm.nih.gov/substance/389599280